OnPoint provides integrated psychiatric care, addiction medicine including Medication-Assisted Treatment (MAT), adult primary care, comprehensive psychiatric evaluations, precision medication management, gene-guided pharmacogenomic testing (GeneSight®), gender-affirming care, hormone replacement therapy evaluation, GLP-1 weight management therapy, and telepsychiatry services across Washington and Oregon.
The practice is led by Dr. Selman Manuel, a Doctor of Nursing Practice (DNP) with multiple board certifications in psychiatric mental health, family practice, and addiction medicine. His advanced clinical expertise guides the integrated care model and treatment plans.
Yes, OnPoint offers secure telepsychiatry appointments for patients throughout Washington State and Oregon, providing executive-level privacy and clinical rigor for remote mental health, addiction, and primary care services.
OnPoint delivers fully integrated care combining psychiatry, addiction medicine, and adult primary care in one coordinated practice. This approach reduces fragmented treatment, improves diagnostic accuracy, aligns medication management with physical health, and supports long-term stability for adults with complex co-occurring conditions.
The practice serves adults aged 18 and older, including professionals, healthcare workers, first responders, individuals with co-occurring psychiatric and medical conditions, LGBTQIA+ patients seeking affirming care, and those needing advanced treatments for ADHD, addiction, mood disorders, or treatment-resistant depression.
You can schedule appointments through the OnPoint official website or via integrated platforms such as Headway, Mindful Therapy Group, Psychology Today, and Zocdoc. Clear calls-to-action on service pages guide you to booking options for in-person or telehealth visits.
Yes, OnPoint provides in-depth adult ADHD evaluations using validated rating scales and thorough history-taking, along with personalized treatment plans including stimulant and non-stimulant medications with careful monitoring and counseling.
OnPoint offers evidence-based Medication-Assisted Treatment (MAT) for opioid and alcohol use disorders, comprehensive dual-diagnosis care for co-occurring psychiatric and substance use disorders, relapse prevention, withdrawal management, and harm reduction strategies within an integrated care framework.
Yes, OnPoint is explicitly LGBTQIA+ owned and affirming, providing trauma-informed, gender-affirming psychiatric and hormone therapy support in a stigma-free environment respectful of diverse identities and minority stress.
OnPoint routinely employs GeneSight® pharmacogenomic testing to personalize psychiatric medication selection based on genetic profiles, reducing trial-and-error prescribing and enhancing safety and efficacy.
OnPoint is developing capacity to offer Spravato® (esketamine) therapy, an advanced, ketamine-based treatment for patients with treatment-resistant depression, integrated within their coordinated care model.
Yes, the practice manages chronic medical conditions such as hypertension, diabetes, obesity, and hormone imbalances alongside psychiatric care, ensuring coordinated treatment plans under one provider.
The initial evaluation includes a comprehensive mental health history, structured clinical assessments, safety screenings, and development of a personalized treatment plan with clear goals and follow-up strategies.
OnPoint provides executive-level privacy through secure telehealth platforms and discreet in-person services. The practice emphasizes confidentiality, especially for professionals, executives, and patients seeking stigma-free mental health and addiction care.
OnPoint accepts flexible digital payments including CashApp and Venmo. Appointment booking platforms often provide insurance information. Patients are encouraged to verify coverage for telehealth and integrated services with their insurance providers.
No, OnPoint operates by appointment only, prioritizing structured, in-depth evaluations and follow-ups rather than high-volume, walk-in or quick-prescribing models.
Yes, OnPoint provides comprehensive hormone replacement therapy evaluations and gender-affirming hormone therapy consultations tailored to individual needs within an inclusive, affirming environment.
The practice integrates psychiatric treatment with metabolic health management, including GLP-1 receptor agonist therapies for weight management, to optimize overall health and minimize side effects from psychotropic medications.
OnPoint follows a conservative, evidence-based medication management philosophy with regular reviews, side effect monitoring, and adjustment based on structured assessments and pharmacogenomic insights.
Appointments are deliberately structured to be thorough and unhurried, allowing sufficient time for detailed evaluation, discussion, and collaborative treatment planning tailored to patient needs.